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care community be aware of changes,
particularly from the perspective of
bench use. As we move into the 21st cen-
tury, common pathogens spread and new
methods and regulatory requirements
potentially affect diagnostic testing. In-
ternational travel and world events com-
pel the local medical community to
broaden its scope beyond its comfort
zone, with regard to the broad range of
parasitic organisms.
This book is successfully organized into
8 sections that present the diagnosis of
pathological parasites in a context that
promotes the best patient care and clinical
outcome. The text has 464 pages of in-
formation, tables, charts, algorithms, and
photographs that greatly expand upon the
first edition. New aspects of the field have
been addressed in new sections, and many
figures and plates have been added. Sec-
tion 1 expounds upon the philosophy and
approach to diagnostic parasitology, in-
cluding the implications of global warm-
ing, population movements, potential out-
break testing, the development of labo-
ratory test menus, and risk management
issues related to urgent and expedited
testing (collection, processing, testing, re-
porting of thick and thin blood films, and
the examination of cerebrospinal fluid and
other specimens for free-living amoebae).
Section 2 is arranged by parasite classifi-
cation and corresponding body sites. Or-
ganism classification and relevant tables are
very helpful in providing the user with cur-
rent information about changes in nomen-
clature and the overall importance of the
various parasite categories to human infec-
tion. Table 2.2 has the unusual title of “Cos-
mopolitan distribution of common para-
sitic infections.” Section 3, “Collection op-
tions,” has detailed information on stool
specimen fixatives and testing options. This
information applies to newer fecal immu-
noassays; the author suggests that clinicians
should always check the literature from the
relevant company for the United States
Food and Drug Administration status of a
new product. There is a thorough discus-
sion on blood collection, including the pros
and cons of current changes from finger
stick blood to venipuncture; tables help to
summarize potential problems with blood
parasite morphology and lag time issues.
There are a number of algorithms in
Section 4, “Specimen test options: routine
diagnostic methods and body sites,” and
Section 5, “Specific test procedures and
algorithms.” These algorithms, specific
sets of instructions for carrying out a di-
agnostic procedure, are useful. Algorithm
5.6 is titled “Ordering algorithm for lab-
oratory examination of intestinal para-
sites,” and it has a detailed notes sec-
tion to assist readers for whom the flow
chart does not provide enough detail. In
Section 6, “Commonly asked questions
about diagnostic parasitology,” the author
successfully captures questions regarding
methods. For instance, there are 10 ques-
tions on the use of permanent stains, in-
cluding “What recent changes have influ-
enced the overall quality of the permanent
stained smear?” Useful and up-to-date in-
formation is also included, such as where
to obtain serologies for a Baylisascaris pro-
cyonis infection, found in the Helminths
subcategory of questions.
Section 7, “Parasite identification,” is
comprehensive, and information on each
organism has been formatted on facing
pages for easy access and reference. Per-
haps color plates could have facilitated
identification of some organisms, but this
would have raised the cost of the text sig-
nificantly. Each of the organisms has a
flow chart of its life cycle. All organisms
have black-and-white plates and many
have drawings, which are helpful with
clinical images not commonly seen in
other diagnostic texts. Section 8, “Identi-
fication aids,” has numerous tables and
plates, including Table 8.34 titled “Key
characteristics of intestinal tract and uro-
genital system protozoa”; these organisms
are each identified as pathogenic or non-
pathogenic.
Because there have been many changes
in clinical laboratories within the past few
years and because these authors have both
teaching and diagnostic bench experience,
this text will prove valuable to the user.
An analysis of trends indicates that the
laboratory of the future will be both ed-
ucational and consultative, especially if the
services are within the microbiology area.
There are few negatives about this prac-
tical book. With changes in collection,
testing, reporting, and interpretation op-
tions, this book needs to be readily avail-
able to the client base of any given labo-
ratory, especially if test orders and results
are to be used for optimal patient out-
comes. Laboratories are increasingly re-
viewing specimen collection options, par-
ticularly with regard to their geographic
area and the types of patients served.
Given that parasitic infections play a piv-
otal role in the overall health and economy
of the world, this book is an important
addition to the resources available to cli-
nicians and laboratory workers.
Aditya Reddy
Lafayette College, Department of Biology,
Easton, Pennsylvania
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A Decade of HAART: The Development and
Global Impact of Highly Active Antiretro-
viral Therapy builds on a conference with
a similar title that the International As-
sociation of Physicians in AIDS Care or-
ganized in 2006. The objective of the book
is to “memorialize what has become one
of the most dramatic successes of medical
care in the past 50 years.” The editors
comprise a clinician, a sociologist, an
economist, and a public health specialist,
and the list of authors is truly impressive:
74 authors from 20 countries contributed
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to the 29 chapters. The book is organized
in 3 sections. The first part gives a his-
torical overview from the discovery of hu-
man immunodeficiency virus (HIV) to re-
cent developments in therapy for both
high-income and low-income countries.
The second part describes the epidemi-
ology of HIV infection and the introduc-
tion of highly active antiretroviral therapy
(HAART) in selected countries, as well as
the design and findings from 8 HIV cohort
studies. The third part discusses the chal-
lenges in the next decade of HAART, in-
cluding the gap in HIV care and access to
HAART between high-income and low-
income countries.
The foreword by Luc Montagnier and
Robert Gallo is one highlight: it gives a
lively and concise account from the dis-
covery of HIV to the introduction of
HAART and its failure to eradicate HIV.
Montagnier and Gallo argue that the pro-
found immunodeficiency associated with
HIV infection and the incomplete im-
mune recovery achieved by HAART ex-
plain why the virus persists. They end on
an optimistic note: in future decades, ad-
ditional treatments aimed at boosting the
immune response might achieve long-
term suppression without HAART. De-
spite some overlap, the first and the last
sections of the book include many excel-
lent chapters, which are well referenced.
The chapter by Roger Paredes, Renslow
Sherer, and Bonaventura Clotet titled “The
clinical challenges of lifetime HAART” is
particularly comprehensive, citing 322 ref-
erences. Zuniga and Ghaziani, in their
chapter on “A world ravaged by a disease
without HAART,” give a gripping account
of the early years, the “Dark Ages” of HIV/
AIDS treatment, and the response of civil
society and the health professions. In their
chapter titled “Redefining HIV/AIDS care
delivery in the face of human resource
scarcity,” Mario Roberto Dal Poz, Norbert
Dreesch, and Dingie van Rensburg argue
for a paradigm shift in allocating care and
human resources: all other health pro-
grams will suffer if no integrated solution
is found. One noteworthy omission is a
chapter that addresses treatment as pre-
vention and more generally that addresses
the place of HAART and HAART pro-
grams in preventing the spread of HIV.
The middle section, which fills 20 of the
29 chapters, is the weakest part of this
book. One wonders here whether less
might have been more: this is a conve-
nience sample of country profiles and de-
scriptions of cohort studies, with little
evidence of editorial and conceptual
guidance. The chapters are heterogeneous
in their approach, and some are fairly su-
perficial. Some are more interesting than
others; for example, the account from
China provides a wealth of information
on the scale-up (or lack thereof) of the
National Free Antiretroviral Treatment
Program. Zhang Fu-Jie, Ray Y. Chen, Se-
lina N. Lo, and Ma Ye report that only
20% of the estimated 650,000 people with
HIV living in China in 2006 had been
identified, and of those identified, ∼20%
had started HAART. This number has now
almost doubled, according to a recent
journal article by some of the same au-
thors [1]. Surprisingly, the median CD4
cell count at the start of HAART decreased
from 159 cells/mL to 118 cells/mL. We ob-
served opposite trends during scale-up of
HAART in sub-Saharan Africa [2].
In summary, this book provides a fas-
cinating and accessible account of the first
decade of HAART and of 25 years of HIV
infection that will be of interest to many.
Much remains to be done, however, before
the final account of this intriguing story
can be written.
Olivia Keiser and Matthias Egger
Institute of Social and Preventive Medicine,
University of Bern, Bern, Switzerland
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